|Mutations driving CLL and their evolution in progression and relapse|
DA Landau, E Tausch, AN Taylor-Weiner, C Stewart, JG Reiter, J Bahlo, ...
Nature 526 (7574), 525-530, 2015
|From pathogenesis to treatment of chronic lymphocytic leukaemia|
T Zenz, D Mertens, R Küppers, H Döhner, S Stilgenbauer
Nature Reviews Cancer 10 (1), 37-50, 2010
|Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial|
S Stilgenbauer, A Schnaiter, P Paschka, T Zenz, M Rossi, K Döhner, ...
Blood, The Journal of the American Society of Hematology 123 (21), 3247-3254, 2014
|The cdc25B phosphatase is essential for the G2/M phase transition in human cells|
C Lammer, S Wagerer, R Saffrich, D Mertens, W Ansorge, I Hoffmann
Journal of cell science 111 (16), 2445-2453, 1998
|Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation …|
T Zenz, S Haebe, T Denzel, J Mohr, D Winkler, A Bühler, A Sarno, ...
Blood, The Journal of the American Society of Hematology 114 (13), 2589-2597, 2009
|miR-34a as part of the resistance network in chronic lymphocytic leukemia|
T Zenz, J Mohr, E Eldering, AP Kater, A Bühler, D Kienle, D Winkler, ...
Blood, The Journal of the American Society of Hematology 113 (16), 3801-3808, 2009
|Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study|
L Pagano, CG Valentini, A Pulsoni, S Fisogni, P Carluccio, F Mannelli, ...
haematologica 98 (2), 239, 2013
|DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia|
CC Oakes, M Seifert, Y Assenov, L Gu, M Przekopowitz, AS Ruppert, ...
Nature genetics 48 (3), 253-264, 2016
|High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations|
J Edelmann, K Holzmann, F Miller, D Winkler, A Bühler, T Zenz, ...
Blood, The Journal of the American Society of Hematology 120 (24), 4783-4794, 2012
|Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated …|
C Korz, A Pscherer, A Benner, D Mertens, C Schaffner, E Leupolt, ...
Blood, The Journal of the American Society of Hematology 99 (12), 4554-4561, 2002
|Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia|
CC Oakes, R Claus, L Gu, Y Assenov, J Hüllein, M Zucknick, M Bieg, ...
Cancer discovery 4 (3), 348-361, 2014
|Epigenetic Upregulation of lncRNAs at 13q14.3 in Leukemia Is Linked to the In Cis Downregulation of a Gene Cluster That Targets NF-kB|
A Garding, N Bhattacharya, R Claus, M Ruppel, C Tschuch, K Filarsky, ...
PLoS genetics 9 (4), e1003373, 2013
|Circulating microRNAs in hematological diseases: principles, challenges, and perspectives|
S Grasedieck, A Sorrentino, C Langer, C Buske, H Döhner, D Mertens, ...
Blood, The Journal of the American Society of Hematology 121 (25), 4977-4984, 2013
|Off-target effects of siRNA specific for GFP|
C Tschuch, A Schulz, A Pscherer, W Werft, A Benner, A Hotz-Wagenblatt, ...
BMC molecular biology 9 (1), 1-14, 2008
|Impact of serum storage conditions on microRNA stability|
S Grasedieck, N Schöler, M Bommer, JH Niess, H Tumani, A Rouhi, ...
Leukemia 26 (11), 2414-2416, 2012
|Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia|
R Claus, DM Lucas, S Stilgenbauer, AS Ruppert, L Yu, M Zucknick, ...
Journal of Clinical Oncology 30 (20), 2483, 2012
|B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions|
S Wolf, D Mertens, C Schaffner, C Korz, H Döhner, S Stilgenbauer, ...
Human molecular genetics 10 (12), 1275-1285, 2001
|Down-regulation of candidate tumor suppressor genes within chromosome band 13q14. 3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia|
D Mertens, S Wolf, P Schroeter, C Schaffner, H Döhner, S Stilgenbauer, ...
Blood, The Journal of the American Society of Hematology 99 (11), 4116-4121, 2002
|NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG|
A Schnaiter, P Paschka, M Rossi, T Zenz, A Bühler, D Winkler, M Cazzola, ...
Blood, The Journal of the American Society of Hematology 122 (7), 1266-1270, 2013
|Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis …|
DL Kienle, C Korz, B Hosch, A Benner, D Mertens, A Habermann, ...
Journal of Clinical Oncology 23 (16), 3780-3792, 2005